Asha Therapeutics has announced its rebranding as First Atom Therapeutics ("First Atom"), marking the company's evolution as a zero-shot de novo drug design company using AI-enabled molecular design ...
About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane receptors called G protein-coupled receptors (GPCRs). GPCRs are indispensable for ...